FcεRI and FcγRIII/CD16 Differentially Regulate Atopic Dermatitis in Mice

被引:17
作者
Abboud, Georges [1 ,2 ]
Staumont-Salle, Delphine [1 ,2 ,3 ]
Kanda, Akira [1 ,2 ]
Roumier, Thomas [1 ,2 ]
Deruytter, Nathalie [1 ,2 ]
Lavogiez, Celine [1 ,2 ]
Fleury, Sebastien [1 ,2 ]
Remy, Patrick [1 ,2 ]
Papin, Jean-Paul [1 ,2 ]
Capron, Monique [1 ,2 ]
Dombrowicz, David [1 ,2 ]
机构
[1] Inst Pasteur, INSERM, Unite 547, F-59019 Lille, France
[2] Univ Lille 2, Lille, France
[3] Ctr Hosp Reg Univ Lille, Dept Dermatol, Lille, France
关键词
MAST-CELLS; GAMMA-CHAIN; AIRWAY HYPERRESPONSIVENESS; BASOPHILS PLAY; IGE; ASTHMA; ALPHA; INFLAMMATION; ANAPHYLAXIS; EXPRESSION;
D O I
10.4049/jimmunol.0801055
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The high-affinity IgE receptor Fc epsilon RI and, in some models, the low-affinity IgG receptor Fc gamma RIII/CD16 play an essential role in allergic diseases. In human skin, they are present on APCs and effector cells recruited into the inflamed dermis. FcR gamma is a subunit shared, among other FcRs, by Fc epsilon RI and CD16 and is essential to their assembly and signal transduction. Using an experimental model reproducing some features of human atopic dermatitis and specific FcR-deficient mice, we have herein delineated the respective contribution of Fc epsilon RI and Fc gamma RIII/CD16 to the pathology. We demonstrate that symptoms of atopic dermatitis are completely absent in FcR gamma-deficient animals but only partially inhibited in either Fc epsilon RI- or Fc gamma RIII/CD16-deficient animals. Absence or attenuation of the pathology is correlated to increased skin expression of regulatory IL-10 and Foxp3. While Fc epsilon RI controls both Th1 and Th2 skin response, mast cell recruitment into draining lymph nodes and IgE production, CD16 regulates only Th2 skin response, as well as T cell proliferation and IgG I production. This isotype-specific regulation by the cognate FcR is associated to a differential regulation of IL-4 and IL-21 expression in the draining lymph nodes. Fc epsilon RI and CD16 thus contribute to atopic dermatitis but differentially regulate immune responses associated with the disease. Targeting both IgE/Fc epsilon RI and IgG/CD16 interactions might represent an efficient therapeutic strategy for allergic diseases. The Journal of Immunology, 2009, 182: 6517-6526.
引用
收藏
页码:6517 / 6526
页数:10
相关论文
共 52 条
[31]   Mast cells in the promotion and limitation of chronic inflammation [J].
Metz, Martin ;
Grimbaldeston, Michele A. ;
Nakae, Susumu ;
Piliponsky, Adrian M. ;
Tsai, Mindy ;
Galli, Stephen J. .
IMMUNOLOGICAL REVIEWS, 2007, 217 :304-328
[32]  
MITCHELL EB, 1982, LANCET, V1, P127
[33]   The genetics of atopic dermatitis [J].
Morar, Nilesh ;
Willis-Owen, Saffron A. G. ;
Moffatt, Miriam F. ;
Cookson, William O. C. M. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (01) :24-34
[34]   Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells [J].
Mukai, K ;
Matsuoka, K ;
Taya, C ;
Suzuki, H ;
Yokozeki, H ;
Nishioka, K ;
Hirokawa, K ;
Etori, M ;
Yamashita, M ;
Kubota, T ;
Minegishi, Y ;
Yonekawa, H ;
Karasuyama, H .
IMMUNITY, 2005, 23 (02) :191-202
[35]   INDUCTION BY ANTIGEN OF INTRATHYMIC APOPTOSIS OF CD4+CD8+TCRLO THYMOCYTES INVIVO [J].
MURPHY, KM ;
HEIMBERGER, AB ;
LOH, DY .
SCIENCE, 1990, 250 (4988) :1720-1723
[36]   Divergent immunoglobulin G subclass activity through selective Fc receptor binding [J].
Nimmerjahn, F ;
Ravetch, JV .
SCIENCE, 2005, 310 (5753) :1510-1512
[37]   Fcγ receptors as regulators of immune responses [J].
Nimmerjahn, Falk ;
Ravetch, Jeffrey V. .
NATURE REVIEWS IMMUNOLOGY, 2008, 8 (01) :34-47
[38]   Evidence for a differential expression of the FcεRIγ chain in dendritic cells of atopic and nonatopic donors [J].
Novak, N ;
Tepel, C ;
Koch, S ;
Brix, K ;
Bieber, T ;
Kraft, S .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (07) :1047-1056
[39]   Basophils are essential initiators of a novel type of chronic allergic inflammation [J].
Obata, Kazushige ;
Mukai, Kaori ;
Tsujimura, Yusuke ;
Ishiwata, Kenji ;
Kawano, Yohei ;
Minegishi, Yoshiyuki ;
Watanabe, Naohiro ;
Karasuyama, Hajime .
BLOOD, 2007, 110 (03) :913-920
[40]   Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challenge [J].
Ong, YE ;
Menzies-Gow, A ;
Barkans, J ;
Benyahia, F ;
Ou, TT ;
Ying, S ;
Kay, AB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (03) :558-564